{
    "relation": [
        [
            "Disease",
            "autoimmune thyroid disease",
            "autoimmune diseases",
            "graves disease",
            "autoimmunity",
            "hashimotos thyroiditis"
        ],
        [
            "-log(P)",
            "84.6",
            "84.2",
            "82.3",
            "80.1",
            "75.3"
        ],
        [
            "Hits",
            "47",
            "126",
            "92",
            "65",
            "25"
        ],
        [
            "PubMed IDs",
            "9285944 (1) 9350448 (1) 9421385 (1) 9421386 (1) 9861324 (2)",
            "7504299 (1) 7520604 (1) 8817351 (2) 9617561 (1) 9861324 (2)",
            "7829637 (1) 8780695 (1) 8817351 (1) 8989248 (3) 9231050 (3)",
            "9200944 (1) 9353155 (1) 9617561 (1) 9849050 (1) 10375557 (1)",
            "9398726 (4) 9421386 (1) 9672157 (1) 10907987 (1) 11288988 (1)"
        ]
    ],
    "pageTitle": "CTLA4 Gene - GeneCards | CTLA4 Protein | CTLA4 Antibody",
    "title": "",
    "url": "http://www.genecards.org/cgi-bin/carddisp.pl?gene=CTLA4&bioalma_dis=93",
    "hasHeader": true,
    "headerPosition": "FIRST_ROW",
    "tableType": "RELATION",
    "tableNum": 11,
    "s3Link": "common-crawl/crawl-data/CC-MAIN-2015-32/segments/1438042988930.94/warc/CC-MAIN-20150728002308-00168-ip-10-236-191-2.ec2.internal.warc.gz",
    "recordEndOffset": 473744599,
    "recordOffset": 473664595,
    "tableOrientation": "HORIZONTAL",
    "TableContextTimeStampBeforeTable": "{57932=This gene is a member of the immunoglobulin superfamily and encodes a protein which transmits an inhibitory signal to T cells. The protein contains a V domain, a transmembrane domain, and a cytoplasmic tail. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. The membrane-bound isoform functions as a homodimer interconnected by a disulfide bond, while the soluble isoform functions as a monomer. Mutations in this gene have been associated with insulin-dependent diabetes mellitus, Graves disease, Hashimoto thyroiditis, celiac disease, systemic lupus erythematosus, thyroid-associated orbitopathy, and other autoimmune diseases. [provided by RefSeq, Jul 2008]}",
    "textBeforeTable": "(50) Novoseek inferred chemical compound relationships for CTLA4 Gene 17139284 17016423 target 3458-28-4 Alpha-D-Mannose PubMed IDs Actions Type Cas Number Synonyms Compound (1) Drugbank Compounds for CTLA4 Gene Engineered fusion proteins consisting of the extracellular domain of CTLA4 and the IgG Fc region (Ctla4-Ig), inhibit T-cell-dependent antibody responses, and are used as immunosuppressive agents. They are soluble, have an enhanced affinity for B7 ligands and act as a competitive inhibitor of CD28 Pharmaceutical: P16410-CTLA4_HUMAN UniProtKB/Swiss-Prot:",
    "textAfterTable": "Drug/compound Annotation bortezomib CA dexamethasone CA melphalan CA prednisone CA Genes that share compounds with CTLA4: view Transcripts for CTLA4 Gene mRNA/cDNA for CTLA4 Gene (22) Selected AceView cDNA sequences: BV183431 AI819438 BC070162 BE837454 BG058720 BC074893 AF414120",
    "hasKeyColumn": true,
    "keyColumnIndex": 0,
    "headerRowIndex": 0
}